Are Grüns And Rhode Outliers Or A New Blueprint For Building Billion-Dollar Brands Faster?

After Unilever’s $1.2 billion acquisition of Grüns, a supplement brand that grew to over $300 million in less than three years and represents one of the fastest inception-to-unicorn sale trajectories in consumer packaged goods, made headlines last week, Drew Fallon, co-founder and CEO of artificial intelligence-powered financial platform Iris Finance, …

Rachel Brown·April 21, 2026·1 min read

The 30-second read

After Unilever’s $1.2 billion acquisition of Grüns, a supplement brand that grew to over $300 million in less than three years and represents one of the fastest inception-to-unicorn sale trajectories in consumer packaged goods, made headlines last week, Drew Fallon, co-founder and CEO of artificial intelligence-powered financial platform Iris Finance, asked a seemingly simple question on X: “Why are these consumer brands growing so fast?”

Coupled with Rhode’s rapid path to exit—it took just over three years to sell to E.l.f. Beauty for roughly $1 billion—we found ourselves asking the same thing. For this edition of our ongoing series posing questions relevant to indie beauty, we put that question to seven investors, along with a few follow-ups:

Do you think the conditions enabling today’s breakout consumer brands to scale so quickly will persist? What does that mean for the pace, profile and pricing of beauty and wellness M&A going forward? And what would you say to an emerging brand aiming to follow in Grüns’ or Rhode’s footsteps?

CAPITAL

Obagi Medical Sells To Bridgepoint For $460M As Beauty’s Ties To Aesthetics Deepen

5 min · Rachel Brown

CAPITAL

Bridge Mentorship’s New Cohort Reveals True Beauty Ventures’ Views On Beauty’s Next Winners

3 min · Jane Carlson

CAPITAL

Violette_FR Lands $5M From Existing Investors In Tough Makeup Funding Market

4 min · Rachel Brown